Siga Technologies secures Tecovirimat FDA approval for smallpox treatment

pharmanewsdaily- July 14, 2018

Siga Technologies has achieved a significant milestone with the U.S. Food and Drug Administration's (FDA) approval of its orally administered antiviral drug, TPOXX (tecovirimat), for ... Read More